Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer

被引：0
|
作者：
Matti S. Aapro
Stephen Chaplin
Paul Cornes
Sebastian Howe
Hartmut Link
Natalia Koptelova
Andrea Mehl
Mario Di Palma
Bridgette Kanz Schroader
Robert Terkola
机构：
[1] Genolier Cancer Center,Gustave Roussy
[2] Xcenda UK,undefined
[3] Comparative Outcomes Group,undefined
[4] Sandoz International GmbH,undefined
[5] Private Practice Hematology Oncology Kaiserslautern,undefined
[6] Paris-Saclay University,undefined
[7] Xcenda LLC,undefined
[8] a Cencora company,undefined
[9] University Medical Center,undefined
[10] Paracelsus Medical University,undefined
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Febrile neutropenia; Cost-effectiveness; Filgrastim; Biosimilar; Pegfilgrastim;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
    Aapro, Matti S.
    Chaplin, Stephen
    Cornes, Paul
    Howe, Sebastian
    Link, Hartmut
    Koptelova, Natalia
    Mehl, Andrea
    Di Palma, Mario
    Schroader, Bridgette Kanz
    Terkola, Robert
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (10)
  • [2] COST-EFFECTIVENESS OF GRANULOCYTE COLONY STIMULATING FACTORS (G-CSFS) FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN BREAST CANCER PATIENTS
    Koptelova, N.
    Mehl, A.
    Chaplin, S.
    Maiese, B. A.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S85 - S85
  • [3] Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models
    Fust, Kelly
    Parthan, Anju
    Maschio, Michael
    Gu, Qing
    Li, Xiaoyan
    Lyman, Gary H.
    Tzivelekis, Spiros
    Villa, Guillermo
    Weinstein, Milton C.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 39 - 52
  • [4] COST-UTILITY OF GRANULOCYTE-COLONY STIMULATING FACTORS (G-CSFS) FOR PRIMARY PROPHYLAXIS (PP) OF CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (FN) IN BREAST CANCER PATIENTS IN THE NETHERLANDS
    Somers, L.
    Timmer-Bonte, J. N. H.
    Gelderblom, H.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A415 - A415
  • [5] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    Kelly, S.
    Wheatley, D.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 : S6 - S10
  • [6] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    S Kelly
    D Wheatley
    [J]. British Journal of Cancer, 2009, 101 : S6 - S10
  • [7] COST-EFFECTIVENESS OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AS ADJUNCTIVE THERAPY IN CANCER PATIENTS WITH ESTABLISHED FEBRILE NEUTROPENIA
    Tong, W. X.
    Wang, X. J.
    Chan, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A912 - A912
  • [8] COST-EFFECTIVENESS AND COST-UTILITY OF GRANULOCYTE COLONY-STIMULATING FACTORS IN THE PRIMARY PROPHYLAXIS OF CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (FN) IN BREAST CANCER PATIENTS IN GREECE: A COMPARATIVE ANALYSIS
    Kourlaba, G.
    Palaka, E.
    Papagiannopoulou, V
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A633 - A633
  • [9] Cost-Effectiveness of Granulocyte Colony-Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom
    Whyte, Sophie
    Cooper, Katy L.
    Stevenson, Matt D.
    Madan, Jason
    Akehurst, Ron
    [J]. VALUE IN HEALTH, 2011, 14 (04) : 465 - 474
  • [10] Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan
    Tseng, Tzu-Hsuan
    Chiang, Shao-Chin
    Hsu, Jason C.
    Ko, Yu
    [J]. PLOS ONE, 2024, 19 (06):
12345